SeekPeptides members access built-in tracking tools that integrate with protocol recommendations, automatically suggesting adjustments based on logged progress
Mechanistic pathways identified in animal and in vitro work include: FAK-paxillin pathway activation: BPC-157 stimulates focal adhesion kinase (FAK) and its downstream effectors, promoting fibroblast migration and tendon cell outgrowth
Selected recent literature for research reference: Mendias CL et al
Originally characterized by the Sikiric group at the University of Zagreb School of Medicine, BPC-157 is unusual among peptides for its reported oral activity attributed to its origin in gastric juice, which suggests evolutionary adaptation to the digestive environment
A 10 mg vial, when properly reconstituted, provides approximately 2040 standard doses depending on the protocol dose
Third-party lab tested at >99% purity